Primary Site >> Colorectal Cancer

Gene >> PRKG1

  • 1994
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2008
  • 2010
  • 2012
  • 2013
  • 2016
  • 2017
Ref: Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
PMID: 8180230
Ref: Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1.
PMID: 11278263
Ref: Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
PMID: 11602670
Ref: [Action of apoptosis-induced ligand gene in relation to tumor necrosis factor on human colon cancer cell line HT29].
PMID: 12015033
Ref: Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.
PMID: 12492113
Ref: beta-Catenin signaling: therapeutic strategies in oncology.
PMID: 12642683
Ref: Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.
PMID: 12717839
Ref: Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells.
PMID: 15173009
Ref: Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
PMID: 15526282
Ref: Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment.
PMID: 16091733
Ref: Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
PMID: 16166323
Ref: Gene targeting approach to selectively kill colon cancer cells, with hyperactive K-Ras pathway.
PMID: 16507412
Ref: A role for cyclic-GMP dependent protein kinase in anoikis.
PMID: 16139477
Ref: An anti-tumor role for cGMP-dependent protein kinase.
PMID: 16256267
Ref: Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
PMID: 16546990
Ref: Downregulation of human colon carcinoma cell (COLO-205) proliferation through PKG-MAP kinase mediated signaling cascade by E. coli heat stable enterotoxin (STa), a potent anti-angiogenic and anti-metastatic molecule.
PMID: 17828804
Ref: Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
PMID: 18163459
Ref: Expression of cyclic guanosine monophosphate-dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis.
PMID: 18260092
Ref: Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.
PMID: 18269345
Ref: Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
PMID: 18593937
Ref: PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.
PMID: 20348951
Ref: cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.
PMID: 21426046
Ref: Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer.
PMID: 21702043
Ref: A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and beta-catenin transcriptional activity.
PMID: 22556201
Ref: Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/beta-catenin signaling.
PMID: 23804703
Ref: beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG.
PMID: 26713600
Ref: The interaction between the Wnt/beta-catenin signaling cascade and PKG activation in cancer.
PMID: 28808213
Ref: New dimeric cGMP analogues reduce proliferation in three colon cancer cell lines.
PMID: 29028532